{"name":"Seldar Pharma, Inc.","slug":"seldar-pharma-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Respiratory","slug":"respiratory","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"ASP7147","genericName":"ASP7147","slug":"asp7147","indication":"Treatment of moderate to severe asthma","status":"phase_2"}]}],"pipeline":[{"name":"ASP7147","genericName":"ASP7147","slug":"asp7147","phase":"phase_2","mechanism":"ASP7147 is a small molecule inhibitor of the PI3K delta subunit.","indications":["Treatment of moderate to severe asthma"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxOT1ZsU0xiQ2JFMjRXemRXYVJmWFNQUm1HbENVSDZjRUp3M3Q5eTRCS3hsejRfSW1Pd1ZhTW9KZl92MkE1QkZUR0RwWEtjWVpWYlZWakNFNURFZWVMM2hNSktkQkRTa0w2OEc5clRLcHl3TlI4bEtIYWFwRmQ4OVlta3JnVmlVcWJFckFXWEowTQ?oc=5","date":"2012-09-13","type":"pipeline","source":"Genetic Engineering and Biotechnology News","summary":"Virtual Companies’ Benefits, and Costs, All Too Real - Genetic Engineering and Biotechnology News","headline":"Virtual Companies’ Benefits, and Costs, All Too Real","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":6,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}